(Q37681360)

21 August 2017

1 reference

title

Nonalcoholic fatty liver disease: a review and update (English)

1 reference

metabolic dysfunction–associated steatotic liver disease

21 August 2017

0 references

1 reference

1 reference

Jeffrey R Lewis

1

1 reference

21 August 2017

Smruti R Mohanty

series ordinal

2

1 reference

21 August 2017

publication date

26 January 2010

1 reference

Digestive Diseases and Sciences

21 August 2017

published in

1 reference

21 August 2017

volume

55

1 reference

21 August 2017

issue

3

1 reference

21 August 2017

page(s)

560-578

1 reference

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-1081-0

Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-1081-0

Effect of weight control on hepatic abnormalities in obese patients with fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-1081-0

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-1081-0

Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-1081-0

A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-1081-0

Ursodeoxycholic acid and atorvastatin in the treatment of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-1081-0

Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-1081-0

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-1081-0

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-009-1081-0

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

12 December 2020

Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

1 reference

12 December 2020

Mitochondrial dysfunction and insulin resistance: a matter of lifestyle?

1 reference

12 December 2020

Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial

1 reference

12 December 2020

Mechanisms of disease progression in nonalcoholic fatty liver disease

1 reference

12 December 2020

Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults

1 reference

12 December 2020

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects

1 reference

12 December 2020

Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2

1 reference

12 December 2020

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

1 reference

12 December 2020

Lactic Acidosis in Patients with Diabetes Treated with Metformin

1 reference

12 December 2020

Mitochondrial injury in steatohepatitis.

1 reference

12 December 2020

Orlistat in the treatment of NASH: a case series

1 reference

12 December 2020

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

1 reference

12 December 2020

Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease

1 reference

12 December 2020

Effects of diet-induced moderate weight reduction on intrahepatic and intramyocellular triglycerides and glucose metabolism in obese subjects

1 reference

12 December 2020

Decrease in accumulation of ultrasound contrast microbubbles in non-alcoholic steatohepatitis

1 reference

12 December 2020

Metformin reverses fatty liver disease in obese, leptin-deficient mice

1 reference

12 December 2020

Beyond insulin resistance in NASH: TNF-alpha or adiponectin?

1 reference

12 December 2020

Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis

1 reference

12 December 2020

Pioglitazone versus vitamin E versus placebo for the treatment of non-diabetic patients with non-alcoholic steatohepatitis: PIVENS trial design

1 reference

12 December 2020

Nonalcoholic fatty liver disease in the pediatric population: a review

1 reference

12 December 2020

Kupffer cells in non-alcoholic fatty liver disease: the emerging view.

1 reference

12 December 2020

Review: Current status of therapy in nonalcoholic fatty liver disease

1 reference

12 December 2020

The natural history of nonalcoholic fatty liver: a follow-up study

1 reference

12 December 2020

Recurrence of hepatocellular carcinoma

1 reference

12 December 2020

Non-alcoholic fatty liver disease in the Asia-Pacific region: definitions and overview of proposed guidelines

1 reference

12 December 2020

Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: results of a randomized trial

1 reference

12 December 2020

Body fat distribution, relative weight, and liver enzyme levels: a population-based study.

1 reference

12 December 2020

Metformin in non-alcoholic steatohepatitis.

1 reference

12 December 2020

Safety of oral intake of vitamin E.

1 reference

12 December 2020

Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life

1 reference

12 December 2020

Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease

1 reference

12 December 2020

Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year

1 reference

12 December 2020

Unenhanced CT for assessment of macrovesicular hepatic steatosis in living liver donors: comparison of visual grading with liver attenuation index

1 reference

12 December 2020

Effects of surgical treatment of the metabolic syndrome on liver fibrosis and cirrhosis

1 reference

12 December 2020

Review article: the evolving role of liver biopsy

1 reference

12 December 2020

Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis

1 reference

12 December 2020

Hyaluronic acid, an accurate serum marker for severe hepatic fibrosis in patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

Is NASH underdiagnosed among African Americans?

1 reference

12 December 2020

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

1 reference

12 December 2020

Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma.

1 reference

12 December 2020

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

1 reference

12 December 2020

The NAFLD fibrosis score: A noninvasive system that identifies liver fibrosis in patients with NAFLD

1 reference

12 December 2020

Difference between liver and spleen CT numbers in the normal adult: its usefulness in predicting the presence of diffuse liver disease

1 reference

12 December 2020

Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: a manifestation of lipotoxicity?

1 reference

12 December 2020

Prevalence and risk factors of non-alcoholic fatty liver disease in potential living liver donors in Korea: a review of 589 consecutive liver biopsies in a single center

1 reference

12 December 2020

Associations between plasma adiponectin concentrations and liver histology in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

Tumor necrosis factor (TNF).

1 reference

12 December 2020

Metformin in the treatment of non-alcoholic steatohepatitis: a pilot open label trial

1 reference

12 December 2020

Metformin use in children with nonalcoholic fatty liver disease: an open-label, 24-month, observational pilot study.

1 reference

12 December 2020

Magnetic resonance elastography: non-invasive mapping of tissue elasticity

1 reference

12 December 2020

Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus

1 reference

12 December 2020

A controlled trial of gemfibrozil in the treatment of patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic fatty liver disease

1 reference

12 December 2020

Therapeutic effects of restricted diet and exercise in obese patients with fatty liver

1 reference

12 December 2020

Pathogenesis of non-alcoholic steatohepatitis: human data

1 reference

12 December 2020

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

1 reference

12 December 2020

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

1 reference

12 December 2020

Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia

1 reference

12 December 2020

Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy.

1 reference

12 December 2020

The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients

1 reference

12 December 2020

A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis

1 reference

12 December 2020

NAFLD, obesity, and bariatric surgery

1 reference

12 December 2020

Measurement of the total antioxidant response using a novel automated method in subjects with nonalcoholic steatohepatitis

1 reference

12 December 2020

Natural history of NAFLD: remarkably benign in the absence of cirrhosis

1 reference

12 December 2020

AGA technical review on nonalcoholic fatty liver disease

1 reference

12 December 2020

Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis

1 reference

12 December 2020

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

1 reference

12 December 2020

Does leptin play a role in the pathogenesis of human nonalcoholic steatohepatitis?

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease

1 reference

12 December 2020

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

1 reference

12 December 2020

A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis

1 reference

12 December 2020

The role of postprandial releases of insulin and incretin hormones in meal-induced satiety--effect of obesity and weight reduction

1 reference

12 December 2020

Serum hyaluronate reflects hepatic fibrogenesis in alcoholic liver disease and is useful as a marker of fibrosis

1 reference

12 December 2020

Prevalence and risk factors of fatty liver disease in the Shuiguohu district of Wuhan city, central China

1 reference

12 December 2020

Clinical model for distinguishing nonalcoholic steatohepatitis from simple steatosis in patients with nonalcoholic fatty liver disease

1 reference

12 December 2020

Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liver

1 reference

12 December 2020

Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study

1 reference

12 December 2020

Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1.

1 reference

12 December 2020

Prevention and Reversal of Liver Damage following Biliopancreatic Diversion for Obesity

1 reference

12 December 2020

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

1 reference

12 December 2020

Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Recurrent nonalcoholic steatohepatitis and cirrhosis after liver transplantation

1 reference

12 December 2020

Fatty infiltration of liver in hyperlipidemic patients

1 reference

12 December 2020

Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E.

1 reference

12 December 2020

Serum cytokine and soluble cytokine receptor levels in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

A pilot study of atorvastatin treatment in dyslipemid, non-alcoholic fatty liver patients

1 reference

12 December 2020

The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women

1 reference

12 December 2020

Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship

1 reference

12 December 2020

Sonographic diagnosis of fatty liver using a histogram technique that compares liver and renal cortical echo amplitudes

1 reference

12 December 2020

Evaluation of abnormal liver-enzyme results in asymptomatic patients

1 reference

12 December 2020

The natural history of nonalcoholic fatty liver disease: a population-based cohort study

1 reference

12 December 2020

Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity

1 reference

12 December 2020

Ultrasound contrast agent, Levovist microbubbles are phagocytosed by Kupffer cells-In vitro and in vivo studies

1 reference

12 December 2020

Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis

1 reference

12 December 2020

Hepatic effects of dietary weight loss in morbidly obese subjects

1 reference

12 December 2020

Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone

1 reference

12 December 2020

Noninvasive diagnosis of liver fibrosis in patients with chronic hepatitis C.

1 reference

12 December 2020

Vitamin E-based therapy is effective in ameliorating transaminasemia in nonalcoholic fatty liver disease.

1 reference

12 December 2020

Assessment of hepatic fibrosis with magnetic resonance elastography

1 reference

12 December 2020

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?

1 reference

12 December 2020

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

12 December 2020

The utility of radiological imaging in nonalcoholic fatty liver disease.

1 reference

12 December 2020

The rise and fall of troglitazone

1 reference

12 December 2020

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

1 reference

12 December 2020

Ursodeoxycholic acid or clofibrate in the treatment of non-alcohol-induced steatohepatitis: a pilot study

1 reference

12 December 2020

Nonalcoholic fatty liver disease is associated with carotid atherosclerosis: a case-control study

1 reference

12 December 2020

Hepatic structure and function after modified jejunoileal bypass surgery for obesity

1 reference

12 December 2020

Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis

1 reference

12 December 2020

Steatohepatitis: a tale of two "hits"?

1 reference

12 December 2020

Metformin in the treatment of patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies

1 reference

12 December 2020

Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin e in nonalcoholic steatohepatitis

1 reference

12 December 2020

Efficacy of omega-3 fatty acids, atorvastatin and orlistat in non-alcoholic fatty liver disease with dyslipidemia.

1 reference

12 December 2020

Leptin is required for fibrogenic responses induced by thioacetamide in the murine liver

1 reference

12 December 2020

Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice

1 reference

12 December 2020

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

1 reference

12 December 2020

Nonalcoholic fatty liver disease presenting with an isolated elevated alkaline phosphatase

1 reference

12 December 2020

Leptin augments inflammatory and profibrogenic responses in the murine liver induced by hepatotoxic chemicals

1 reference

12 December 2020

Pediatric nonalcoholic fatty liver disease (NAFLD): a "growing" problem?

1 reference

12 December 2020

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

1 reference

12 December 2020

Diagnosis and therapy of nonalcoholic steatohepatitis

1 reference

12 December 2020

Rosuvastatin as a novel treatment of non-alcoholic fatty liver disease in hyperlipidemic patients.

1 reference

12 December 2020

Noninvasive diagnosis of liver cirrhosis using DNA sequencer-based total serum protein glycomics

1 reference

12 December 2020

Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis

1 reference

12 December 2020

Does retinol-binding protein 4 cause or reflect fatty liver disease?

1 reference

12 December 2020

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a meta-analysis of randomized trials

1 reference

12 December 2020

Appetite suppression and weight loss after the cannabinoid antagonist SR 141716.

1 reference

12 December 2020

Efficacy and safety of oral betaine glucuronate in non-alcoholic steatohepatitis. A double-blind, randomized, parallel-group, placebo-controlled prospective clinical study

1 reference

12 December 2020

Fatty liver in obesity: relation to Doppler perfusion index measurement of the liver

1 reference

12 December 2020

Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment

1 reference

12 December 2020

Blood oxidative stress markers are unreliable markers of hepatic steatosis

1 reference

12 December 2020

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

1 reference

12 December 2020

Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

1 reference

12 December 2020

Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study

1 reference

12 December 2020

Serum leptin levels in patients with nonalcoholic steatohepatitis

1 reference

12 December 2020

Effect of weight reduction on hepatic abnormalities in overweight patients

1 reference

12 December 2020

Weight reduction and long-term maintenance after 18 months treatment with orlistat for obesity

1 reference

12 December 2020

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

1 reference

12 December 2020

Molecular mediators of hepatic steatosis and liver injury

1 reference

12 December 2020

The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis.

1 reference

12 December 2020

Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status

1 reference

12 December 2020

Pioglitazone treatment increases whole body fat but not total body water in patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Management of hepatocellular carcinoma

1 reference

12 December 2020

Hepatic MRI for fat quantitation: its relationship to fat morphology, diagnosis, and ultrasound

1 reference

12 December 2020

Long term prognosis of fatty liver: risk of chronic liver disease and death.

1 reference

12 December 2020

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

12 December 2020

Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management

1 reference

12 December 2020

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

1 reference

12 December 2020

The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis

1 reference

12 December 2020

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

1 reference

12 December 2020

Incretin mimetics as a novel therapeutic option for hepatic steatosis

1 reference

12 December 2020

The evolution of severe steatosis after bariatric surgery is related to insulin resistance

1 reference

12 December 2020

Therapy of NAFLD: antioxidants and cytoprotective agents

1 reference

12 December 2020

Potential role of doppler perfusion index in selection of patients with colorectal cancer for adjuvant chemotherapy

1 reference

12 December 2020

Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease

1 reference

12 December 2020

Pleiotropic effects of statins

1 reference

12 December 2020

Diagnostic criteria for fatty infiltration of the liver on contrast-enhanced helical CT

1 reference

12 December 2020

Health risks among Japanese men with moderate body mass index

1 reference

12 December 2020

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

12 December 2020

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

1 reference

12 December 2020

10.1007/S10620-009-1081-0

Identifiers

DOI

1 reference

21 August 2017

1 reference